We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

MorphoSys Establishes ADR Level One Program in USA

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Morphosys AG has announced the launch of a sponsored ADR (American Depository Receipt) Program Level I in order to support broadening the Company's US investor base.

The trading symbol for MorphoSys's ADR is MPSYY and its CUSIP number is 617760103.

Each MorphoSys ADR represents one MorphoSys ordinary share as traded on the Frankfurt Stock Exchange.

MorphoSys has appointed The Bank of New York as the depositary bank for its ADR Program.

"The launch of our ADR Program is intended to increase access to the U.S. capital markets, and enhance the trading options for existing and potential new investors," commented Dave Lemus, Chief Financial Officer of MorphoSys.